MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,152,471
EPS
-$0.43
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
-
-
-
0
Research and development
267,240
511,878
943,478
1,025,547
General and administrative
1,160,556
1,843,530
886,055
2,346,323
Legal and professional
789,026
432,827
437,409
538,536
Total operating expenses
2,216,822
2,788,235
2,266,942
3,910,406
Net loss from operations
-2,216,822
-2,788,235
-2,266,942
-3,910,406
Interest expense-Related Party
-
3,727.5*
721
2,614
Interest expense
12,122
6,130*
18,183
19,129
Change in fair value of marketable securities
-
-
-
0
Gain on sale of marketable securities
-
-
-
0
Interest income
209
239.5*
486
81
Change in fair value of derivative liabilities
76,264
-91,149
2,427
11,673
Loss on settlement of convertible debt
-
-
-
0
Change in fair value of convertible notes
-
-60,433
-64,369
213,930
Gain on settlement of debt
-
334,540*
-
-
Total other (expense) income
64,351
173,340
-80,360
203,941
Net loss
-2,152,471
-2,614,895
-2,347,302
-3,706,465
Basic EPS
-0.43
-1.596
-1.05
-3.29
Diluted EPS
-0.43
-1.596
-1.05
-3.29
Basic Average Shares
5,031,569
1,637,926*
2,233,650
1,126,054
Diluted Average Shares
5,031,569
1,637,926*
2,233,650
1,126,054
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
derivative liabilities
$76,264
(2785.51%↑ Y/Y)
Interest income
$209
Net loss
-$2,152,471
(29.50%↑ Y/Y)
Total other (expense)
income
$64,351
(163.23%↑ Y/Y)
Interest expense
$12,122
(1.61%↑ Y/Y)
Net loss from
operations
-$2,216,822
(24.89%↑ Y/Y)
Total operating
expenses
$2,216,822
(-24.89%↓ Y/Y)
General and
administrative
$1,160,556
(94.44%↑ Y/Y)
Legal and
professional
$789,026
(1.10%↑ Y/Y)
Research and development
$267,240
(-83.02%↓ Y/Y)
Buy us a coffee
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)